These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7170020)

  • 21. dl- versus meso-3,4-dimethyl-2,5-hexanedione: a morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat.
    Rosenberg CK; Genter MB; Szakál-Quin G; Anthony DC; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):363-73. PubMed ID: 3824390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimethylhexanedione impairs the movement of neurofilament protein subunits, NFM and NFL, in the optic system.
    Pyle SJ; Graham DG; Anthony DC
    Neurotoxicology; 1994; 15(2):279-86. PubMed ID: 7991216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanism of hexane neuropathy: significant differences in pharmacokinetics between 2.3-, 2.4-, and 2.5-hexanedione.
    Iwasaki K; Tsuruta H
    Ind Health; 1984; 22(3):177-87. PubMed ID: 6501003
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of pyrrole formation in the alteration of neurofilament transport induced during exposure to 2,5-hexanedione.
    Pyle SJ; Amarnath V; Graham DG; Anthony DC
    J Neuropathol Exp Neurol; 1992 Jul; 51(4):451-8. PubMed ID: 1619444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative estimation of the neurotoxic risks of N-hexane and N-heptane in rats and humans based on the formation of the metabolites 2,5-hexanedione and 2,5-heptanedione.
    Filser JG; Csanády GA; Dietz W; Kessler W; Kreuzer PE; Richter M; Störmer A
    Adv Exp Med Biol; 1996; 387():411-27. PubMed ID: 8794236
    [No Abstract]   [Full Text] [Related]  

  • 26. Polyneuropathy induced by n-hexane intoxication in Taiwan.
    Huang CC
    Acta Neurol Taiwan; 2008 Mar; 17(1):3-10. PubMed ID: 18564821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hexacarbon neurotoxicity.
    Griffin JW
    Neurobehav Toxicol Teratol; 1981; 3(4):437-44. PubMed ID: 6278344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure.
    DeCaprio AP; O'Neill EA
    Toxicol Appl Pharmacol; 1985 Apr; 78(2):235-47. PubMed ID: 3929425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical studies of acrylamide neuropathy.
    Howland RD
    Neurotoxicology; 1985; 6(4):7-15. PubMed ID: 2935750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic neurofilamentous axonopathies -- accumulation of neurofilaments and axonal degeneration.
    Llorens J
    J Intern Med; 2013 May; 273(5):478-89. PubMed ID: 23331301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofilament protein crosslinking in gamma-diketone neuropathy: in vitro and in vivo studies using the seaworm myxicola infundibulum.
    St Clair MB; Anthony DC; Wikstrand CJ; Graham DG
    Neurotoxicology; 1989; 10(4):743-56. PubMed ID: 2562540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotoxicants and the cytoskeleton.
    Graham DG
    Curr Opin Neurol; 1999 Dec; 12(6):733-7. PubMed ID: 10676757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2,5-hexanedione altered the degradation of low-molecular-weight neurofilament in rat nerve tissues.
    Song F; Zhang Q; Kou R; Zou C; Gao Y; Xie K
    Food Chem Toxicol; 2012 Dec; 50(12):4277-84. PubMed ID: 22967723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing mechanisms of axonopathy. Part II: Protein targets of 2,5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane.
    Tshala-Katumbay D; Monterroso V; Kayton R; Lasarev M; Sabri M; Spencer P
    Toxicol Sci; 2009 Feb; 107(2):482-9. PubMed ID: 19033394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nervous system responses of rats to subchronic inhalation of N-hexane and N-hexane + methyl-ethyl-ketone mixtures.
    Altenkirch H; Wagner HM; Stoltenburg G; Spencer PS
    J Neurol Sci; 1982 Dec; 57(2-3):209-19. PubMed ID: 6891717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. n-Hexane neurotoxicity: a mechanism involving pyrrole adduct formation in axonal cytoskeletal protein.
    DeCaprio AP
    Neurotoxicology; 1987; 8(1):199-210. PubMed ID: 3550536
    [No Abstract]   [Full Text] [Related]  

  • 37. Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy.
    Genter St Clair MB; Amarnath V; Moody MA; Anthony DC; Anderson CW; Graham DG
    Chem Res Toxicol; 1988; 1(3):179-85. PubMed ID: 2979729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that pyrrole formation is a pathogenetic step in gamma-diketone neuropathy.
    Genter MB; Szakál-Quin G; Anderson CW; Anthony DC; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):351-62. PubMed ID: 3103260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hexacarbon neuropathy: tracking a toxin.
    Couri D; Milks MM
    Neurotoxicology; 1985; 6(4):65-71. PubMed ID: 3003628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demyelination in experimental beta, beta'-iminodipropionitrile and hexacarbon neuropathies. Evidence for an axonal influence.
    Griffin JW; Price DL
    Lab Invest; 1981 Aug; 45(2):130-41. PubMed ID: 7265914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.